Predictive Value of Serum Copeptin as a Severity Marker of Community-Acquired Pneumonia in Pediatrics | ||||
| The Medical Journal of Cairo University | ||||
| Volume 90, Issue 6, June 2022, Page 755-769 PDF (254.07 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mjcu.2022.253170 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| MAHMOUD MOHAMED FOUAD, M.B.B.CH.; EMAN MAHMOUD FOUDA, M.D.; EMAN ABDEL-MONIEM EL-GOHARY, M.D.; HEBA ALLAH AHMED ALI, M.D. | ||||
| The Departments of Pediatrics* and Clinical Pharmacy**, Faculty of Medicine, Ain Shams University | ||||
| Abstract | ||||
| Abstract Background: Community-acquired pneumonia is the most severe form of acute respiratory infections. Aim of Study: This study aimed to assess the level of copeptin in community- acquired pneumonia in children. Patients and Methods: A cross- sectional study was conducted on 40 children with community acquired pneumonia and another 30 healthy children as controls. Imaging techniques as X-ray, and computed topography were used to assess the diagnosis of pneumonia. Results: Blood levels of copeptin in children with pneumonia with a median of 55 pmol/L were much higher than copeptin levels in controls groups (p-value <0.001). Pneumonia complications were reported in 15 (50.0%) Conclusion: Serum blood levels of copeptin might be used as a diagnostic measure for community- acquired pneumonia. | ||||
| Keywords | ||||
| Community-acquired pneumonia; CAP; Copeptin; Procalcitonin | ||||
|
Statistics Article View: 183 PDF Download: 157 |
||||
